1. |
Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1:1311-5. doi: 10.1016/s0140-6736(84)91816-6.
doi: 10.1016/s0140-6736(84)91816-6
pmid: 6145023
|
2. |
Ianiro G, Molina-Infante J, Gasbarrini A. Gastric Microbiota. Helicobacter 2015; 20(Suppl 1):68-71. doi: 10.1111/hel.12260.
doi: 10.1111/hel.12260
|
3. |
Leja M, Grinberga-Derica I, Bilgilier C, et al. Review: Epidemiology of Helicobacter pylori infection. Helicobacter 2019; 24(Suppl 1):e12635. doi: 10.1111/hel.12635.
doi: 10.1111/hel.12635
|
4. |
Polk DB, Peek RM Jr. Helicobacter pylori: Gastric cancer and beyond. Nat Rev Cancer 2010; 10(6):403-14. doi: 10.1038/nrc2857.
doi: 10.1038/nrc2857
|
5. |
Dias-Jácome E, Libânio D, Borges-Canha M, et al. Gastric microbiota and carcinogenesis: the role of non-Helicobacter pylori bacteria - A systematic review. Rev Esp Enferm Dig 2016; 108(9):530-40. doi: 10.17235/reed.2016.4261/2016.
doi: 10.17235/reed.2016.4261/2016
pmid: 27604361
|
6. |
Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345(11):784-9. doi: 10.1056/NEJMoa001999.
doi: 10.1056/NEJMoa001999
|
7. |
Ma JL, Zhang L, Brown LM, et al. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst 2012; 104:488-92. doi: 10.1093/jnci/djs003.
doi: 10.1093/jnci/djs003
|
8. |
Li WQ, Ma JL, Zhang L, et al. Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups. J Natl Cancer Inst 2014; 106(7):dju116. doi: 10.1093/jnci/dju116.
doi: 10.1093/jnci/dju116
|
9. |
Wong BC, Zhang L, Ma JL, et al. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions. Gut 2012; 61(6):812-8. doi: 10.1136/gutjnl-2011-300154.
doi: 10.1136/gutjnl-2011-300154
|
10. |
International Agency for Research on Cancer. Helicobacter pylori eradication as a strategy for preventing gastric cancer. IARC working group reports Volume 8. Available from https://www.gastro-health-now.org/wp/wp-content/uploads/2014/09/WHO-IARC-Report-2014.pdf. accessed: January 1.
|
11. |
Pohl D, Keller PM, Bordier V, et al. Review of current diagnostic methods and advances in Helicobacter pylori diagnostics in the era of next generation sequencing. World J Gastroenterol 2019; 25(32):4629-4660. doi: 10.3748/wjg.v25.i32.4629.
doi: 10.3748/wjg.v25.i32.4629
|
12. |
Zhao Y, Gao X, Guo J, et al. Helicobacter pylori infection alters gastric and tongue coating microbial communities. Helicobacter. 2019; 24(2):e12567. doi: 10.1111/hel.12567.
doi: 10.1111/hel.12567
|
13. |
Gantuya B, El Serag HB, Saruuljavkhlan B, et al. Advantage of 16S rRNA amplicon sequencing in Helicobacter pylori diagnosis. Helicobacter 2021; 26(3):e12790. doi: 10.1111/hel.12790.
doi: 10.1111/hel.12790
|
14. |
Park CH, Lee AR, Lee YR, et al. Evaluation of gastric microbiome and metagenomic function in patients with intestinal metaplasia using 16S rRNA gene sequencing. Helicobacter 2019; 24(1):e12547. doi: 10.1111/hel.12547.
doi: 10.1111/hel.12547
|
15. |
Schulz C, Schütte K, Koch N, et al. The active bacterial assemblages of the upper GI tract in individuals with and without Helicobacter infection. Gut 2018; 67(2):216-25. doi: 10.1136/gutjnl-2016-312904.
doi: 10.1136/gutjnl-2016-312904
|
16. |
Parsons BN, Ijaz UZ, D’Amore R, et al. Comparison of the human gastric microbiota in hypochlorhydric states arising as a result of Helicobacter pylori-induced atrophic gastritis, autoimmune atrophic gastritis and proton pump inhibitor use. PLoS Pathog 2017; 13(11):e1006653. doi: 10.1371/journal.
doi: 10.1371/journal
|
17. |
Klymiuk I, Bilgilier C, Stadlmann A, et al. The Human Gastric Microbiome Is Predicated upon Infection with Helicobacter pylori. Front Microbiol 2017; 8:2508. doi: 10.3389/fmicb.2017.02508.
doi: 10.3389/fmicb.2017.02508
|
18. |
Ahn J, Sinha R, Pei Z, et al. Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst 2013; 105(24):1907-11. doi: 10.1093/jnci/djt300.
doi: 10.1093/jnci/djt300
|
19. |
Coker OO, Dai Z, Nie Y, et al. Mucosal microbiome dysbiosis in gastric carcinogenesis. Gut 2018; 67(6):1024-32. doi: 10.1136/gutjnl-2017-314281.
doi: 10.1136/gutjnl-2017-314281
|
20. |
Ferreira RM, Pereira-Marques J, Pinto-Ribeiro I, et al. Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota. Gut 2018; 67(2):226-36. doi: 10.1136/gutjnl-2017-314205.
doi: 10.1136/gutjnl-2017-314205
pmid: 29102920
|
21. |
Palrasu M, Zaika E, El-Rifai W, et al. Role of Bacterial and Viral Pathogens in Gastric Carcinogenesis. Cancers (Basel) 2021; 13(8):1878. doi: 10.3390/cancers13081878.
doi: 10.3390/cancers13081878
|
22. |
Song H, Ekheden IG, Zheng Z, et al. Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population. BMJ 2015; 351:h3867. doi: 10.1136/bmj.h3867.
doi: 10.1136/bmj.h3867
|
23. |
Amieva M, Peek RM Jr. Athobiology of helicobacter pylori-induced gastric cancer. Gastroenterology 2016; 150(1):64-78. doi: 10.1053/j.gastro.2015.09.004.
doi: 10.1053/j.gastro.2015.09.004
|
24. |
Li F, Zhu H, Tao K, et al. Mucosal microbial microenvironment in early gastric neoplasia and non-neoplastic gastric disease. J Gastroenterol Hepatol 2021; 36(11):3092-101. doi: 10.1111/jgh.15565.
doi: 10.1111/jgh.15565
|
25. |
Guo Y, Zhang Y, Gerhard M, et al. Effect of Helicobacter pylori on gastrointestinal microbiota: a population-based study in Linqu, a high-risk area of gastric cancer. Gut 2020; 69(9):1598-607. doi: 10.1136/gutjnl-2019-319696.
doi: 10.1136/gutjnl-2019-319696
|